Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

MINERAL OIL

All products: general benefit

Other products in the same Health Canada class (A06A, A06AA) — coverage varies; not interchangeable

  • Docusate dioctyl sulfosuccinate (Docusate Sodium): general benefit
  • Bisacodyl (Dulcolax): general benefit
  • Citrus fibre + grain (Novo-Fibre): general benefit, Not a benefit
  • Lactulose (PMS-Lactulose): general benefit
  • Citric acid + oxide + picosulfate (Pico-Salax): general benefit

Fleet Enema Mineral Oil · DIN 00107875 · 100% · Enema

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
No interchangeable product listed in the Ontario extract
Fleet Enema Mineral Oil · DIN 00107875 Manufacturer: C.B. Fleet Company Inc.; listing date 1996-10-01 Health Canada: Marketed since 2018-04-02 · brand FLEET ENEMA MINERAL OIL · ATC A06AA01 LIQUID PARAFFIN · form Enema · route Rectal · ingredients MINERAL OIL 100 % · company C b fleet company inc · schedule Non-prescription drugs
Check this DIN again · Health Canada product record

Fleet Enema Mineral Oil: Formulary list price $0.0474/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0474 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=721 · Verify on the e-Formulary ↗ (DIN 00107875)

Source record
DIN 00107875: Fleet Enema Mineral Oil Raw flags: sec3=Y Item: 561200016; group id 653; item number 1635; lccId None; manufacturer id CBF Source form: Enema; strength: 100% Recorded listing: General benefit Source prices (unrounded): $0.0474; ministry $0.0474 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00107875 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=721
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00107875
Shortage record checked 2026-09-13T08:10:21.292534+00:00

PETROLATUM/MINERAL OIL

All strengths: Limited Use — Reason for Use code 49 required; same patient cost rules

Shared coverage and patient cost rules
StatusLimited Use — Reason for Use code 49 required
Patient paysPatient pays: program not supplied; amount cannot be determined.

Other products in the same Health Canada class (A06A, A06AA) — coverage varies; not interchangeable

  • Docusate dioctyl sulfosuccinate (Docusate Sodium): general benefit
  • Bisacodyl (Dulcolax): general benefit
  • Citrus fibre + grain (Novo-Fibre): general benefit, Not a benefit
  • Lactulose (PMS-Lactulose): general benefit
  • Citric acid + oxide + picosulfate (Pico-Salax): general benefit

Lacri-Lube · DIN 00210889 · 55% & 42.5% · Oph Oint-3.5g Pk

Limited Use — Reason for Use code 49 requiredMarketed · checked 2026-09-02
Write on scriptLU code 49 (patient must meet the criteria below)
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
Ontario Limited Use criteria — code 49
Reason for Use code 49 For patients with objective evidence of keratoconjunctivitis sicca as confirmed by filamentary keratopathy on slit lamp examination or biopsy. Coverage limit: LU Authorization Period: Indefinite
No interchangeable product listed in the Ontario extract
Lacri-Lube · DIN 00210889 Manufacturer: Allergan Inc.; listing date 1996-10-01 Health Canada: Marketed since 2024-07-09 · brand REFRESH LACRI-LUBE · ATC S01XA20 ARTIFICIAL TEARS AND OTHER INDIFFERENT PREPARATIONS. · form Ointment · route Ophthalmic · ingredients MINERAL OIL 42.5 %, WHITE PETROLATUM 57.3 % · company Abbvie corporation · schedule Non-prescription drugs
Check this DIN again · Health Canada product record

Lacri-Lube: Formulary list price $7.9000/unit (unit not stated in source; not the patient's cost)

Ministry pays: $7.9000 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=9820 · Verify on the e-Formulary ↗ (DIN 00210889)

Source record
DIN 00210889: Lacri-Lube Raw flags: sec12=Y, sec3=Y Item: 523600070; group id 636; item number 1607; lccId 00091; manufacturer id ALL Source form: Oph Oint-3.5g Pk; strength: 55% & 42.5% Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below Source prices (unrounded): $7.9000; ministry $7.9000 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00210889 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=9820
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00210889
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Soothe Night Time · DIN 02125706 · 80%/20% · Oph Oint-3.5g Pk

Limited Use — Reason for Use code 49 requiredMarketed · checked 2026-09-02
Write on scriptLU code 49 (patient must meet the criteria below)
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
Ontario Limited Use criteria — code 49
Reason for Use code 49 For patients with objective evidence of keratoconjunctivitis sicca as confirmed by filamentary keratopathy on slit lamp examination or biopsy. Coverage limit: LU Authorization Period: Indefinite
No interchangeable product listed in the Ontario extract
Soothe Night Time · DIN 02125706 Manufacturer: Bausch & Lomb Inc.; listing date 1996-10-01 Health Canada: Marketed since 2015-05-29 · brand SOOTHE NIGHT TIME · ATC S01XA20 ARTIFICIAL TEARS AND OTHER INDIFFERENT PREPARATIONS. · form Ointment · route Ophthalmic · ingredients MINERAL OIL 20 %, PETROLATUM 80 % · company Bausch & lomb inc · schedule Non-prescription drugs
Check this DIN again · Health Canada product record

Soothe Night Time: Formulary list price $5.7800/unit (unit not stated in source; not the patient's cost)

Ministry pays: $5.7800 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=16777 · Verify on the e-Formulary ↗ (DIN 02125706)

Source record
DIN 02125706: Soothe Night Time Raw flags: sec12=Y, sec3=Y Item: 523600076; group id 636; item number 1608; lccId 00091; manufacturer id BLI Source form: Oph Oint-3.5g Pk; strength: 80%/20% Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below Source prices (unrounded): $5.7800; ministry $5.7800 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02125706 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=16777
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02125706
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Other drugs in the same formulary classes and how they are covered

Other drugs in the same formulary class (52:36 Other Eye, Ear, Nose and Throat Agents) and how they are covered

Matched class: 52:36 Other Eye, Ear, Nose and Throat Agents

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: BETAXOLOL HCL, DICLOFENAC SODIUM, LEVOBUNOLOL HCL Some products covered without a code (check the product listing): ACETAZOLAMIDE, METHAZOLAMIDE, SODIUM CROMOGLYCATE, TIMOLOL MALEATE 52:36 Other Eye, Ear, Nose and Throat Agents

ACETAZOLAMIDE

· 2 products · General benefit (1), Listed, not a benefit (1) · strengths: 250mg · Tab

BETAXOLOL HCL

· 1 products · General benefit · strengths: 0.25% · Oph Susp

DICLOFENAC SODIUM

· 6 products · General benefit · strengths: 0.1% · Oph Sol

LEVOBUNOLOL HCL

· 1 products · General benefit · strengths: 0.5% · Oph Sol

METHAZOLAMIDE

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 50mg · Tab

SODIUM CROMOGLYCATE

· 2 products · General benefit (1), Listed, not a benefit (1) · strengths: 2% · Oph Sol

TIMOLOL MALEATE

· 10 products · Listed, not a benefit (2), General benefit (8) · strengths: 0.25%, 0.5% · Oph Gellan Sol, Oph Sol

AFLIBERCEPT

· 6 products · Limited Use, codes 729, 730, 731 (4), Limited Use, codes 694, 695 (2) · strengths: 2mg/0.05mL, 8mg/0.07mL · Inj Sol-0.05mL Pref Syr (Preservative-Free), Inj Sol-0.07mL Pref Syr, Inj Sol-0.07mL Vial Pk, Sol for Intravitreal Inj-0.05mL Vial Pk

BIMATOPROST

· 8 products · Listed, not a benefit (1), Limited Use, codes 171, 172, 387 (7) · strengths: 0.03%, 0.01% · Oph Sol, Oph Sol-5mL Pk, Oph Sol-7.5mL Pk

BRIMONIDINE

· 7 products · Limited Use, codes 171, 172, 387 · strengths: 0.15%, 0.2% · Oph Sol

BRIMONIDINE TARTRATE & TIMOLOL MALEATE

· 3 products · Limited Use, codes 310, 393 · strengths: 0.2% & 0.5% · Oph Sol-10mL Pk

BRINZOLAMIDE

· 1 products · Limited Use, codes 171, 172, 387 · strengths: 1% · Oph Susp Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 52:36 and 20 more
Full class listing Related classes: 52:04 Anti-Infectives, 52:08 Anti-Inflammatory Agents, 52:16 Local Anesthetics, 52:20 Miotics, 52:24 Mydriatics, 52:32 Vasoconstrictors

Other drugs in the same formulary class (56:12 Cathartics) and how they are covered

Matched class: 56:12 Cathartics

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: BISACODYL, DOCUSATE SODIUM (DIOCTYL SODIUM SULFOSUCCINATE), LACTULOSE, MAGNESIUM OXIDE & CITRIC ACID & SODIUM PICOSULFATE, PSYLLIUM MUCILLOID, SENNOSIDES A & B, SODIUM BIPHOSPHATE & SODIUM PHOSPHATE Some products covered without a code (check the product listing): GRAIN & CITRUS FIBRE 56:12 Cathartics

DOCUSATE SODIUM (DIOCTYL SODIUM SULFOSUCCINATE)

· 6 products · General benefit · strengths: 100mg, 4mg/mL, 10mg/mL · Cap, O/L

BISACODYL

· 5 products · General benefit · strengths: 5mg, 10mg · Ent Tab, Sup

GRAIN & CITRUS FIBRE

· 2 products · General benefit (1), Listed, not a benefit (1) · strengths: · Tab

LACTULOSE

· 1 products · General benefit · strengths: 667mg/mL · O/L

MAGNESIUM OXIDE & CITRIC ACID & SODIUM PICOSULFATE

· 2 products · General benefit · strengths: 3.5g & 12g & 10mg · Pd for Sol-12g Sachet

PSYLLIUM MUCILLOID

· 1 products · General benefit · strengths: · Oral Pd

SENNOSIDES A & B

· 2 products · General benefit · strengths: 8.6mg · Tab

SODIUM BIPHOSPHATE & SODIUM PHOSPHATE

· 2 products · General benefit · strengths: 160mg & 60mg/mL · Ped Rect Sol, Rect Sol (with Preservative) Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 56:12
Full class listing Related classes: 56:04 Antacids and Adsorbents, 56:08 Antidiarrhea Agents, 56:16 Digestants, 56:22 Antiemetics and Antinauseants, 56:40 Miscellaneous G.I. Drugs Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
Product monograph unavailable: no link
What the Health Canada label says it is for
Product monograph unavailable: no link